Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features-Reference-Cited by-同舟云学术

Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features

Published:2008-08 Issue:8 Volume:19 Page:1387-1392
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bellmunt J.,Szczylik C.,Feingold J.,Strahs A.,Berkenblit A.

Funder

Wyeth Pharmaceuticals

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/19/8/1387/624706/mdn066.pdf

Reference22 articles.

1. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E;Fingar;Mol Cell Biol,2004

2. Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin;Hudson;Mol Cell Biol,2002

3. TOR, a central controller of cell growth;Schmelzle;Cell,2000

4. Design, synthesis and biological evaluation of C-42 hydroxyesters of rapamycin: the identification of CCI-779 [abstract];Skotnicki;Clin Cancer Res,2001

5. The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy;Abraham;Clin Cancer Res,2007

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations between Diabetes Mellitus and Selected Cancers;International Journal of Molecular Sciences;2024-07-08

2. A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors;Cancers;2024-03-13

3. Cardiovascular Toxicity of Angiogenesis Inhibitors Among Patients With Cancer in Taiwan: A Nested Case‐Control Study;Journal of the American Heart Association;2024-01-02

4. First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2023-05-04

5. Drug repurposing approach against chikungunya virus: an in vitro and in silico study;Frontiers in Cellular and Infection Microbiology;2023-04-27